Messenger RNA Therapy for Female Reproductive Health
R VanKeulen-Miller, OS Fenton - Molecular Pharmaceutics, 2024 - ACS Publications
Female reproductive health has traditionally been an underrepresented area of research in
the drug delivery sciences. This disparity is also seen in the emerging field of mRNA …
the drug delivery sciences. This disparity is also seen in the emerging field of mRNA …
Lipid Nanoparticle (LNP) Delivery Carrier-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity
L Wu, X Li, X Qian, S Wang, J Liu, J Yan - Vaccines, 2024 - mdpi.com
In recent years, lipid nanoparticles (LNPs) have attracted extensive attention in tumor
immunotherapy. Targeting immune cells in cancer therapy has become a strategy of great …
immunotherapy. Targeting immune cells in cancer therapy has become a strategy of great …
A trivalent HSV-2 gC2, gD2, gE2 nucleoside-modified mRNA-LNP vaccine provides outstanding Protection in mice against genital and non-genital HSV-1 infection …
KP Egan, S Awasthi, G Tebaldi, LM Hook… - Viruses, 2023 - mdpi.com
HSV-1 disease is a significant public health burden causing orofacial, genital, cornea, and
brain infection. We previously reported that a trivalent HSV-2 gC2, gD2, gE2 nucleoside …
brain infection. We previously reported that a trivalent HSV-2 gC2, gD2, gE2 nucleoside …
Debulking Influenza and Herpes Simplex virus strains by a wide-spectrum anti-viral protein formulated in clinical grade chewing gum.
ABSTRACT Lack of Herpes Simplex Virus (HSV) vaccine, low vaccination rates of Influenza
viruses, waning immunity and viral transmission after vaccination underscore the need to …
viruses, waning immunity and viral transmission after vaccination underscore the need to …
[HTML][HTML] Carrier-free mRNA vaccine induces robust immunity against SARS-CoV-2 in mice and non-human primates without systemic reactogenicity
S Abbasi, M Matsui-Masai, F Yasui, A Hayashi… - Molecular Therapy, 2024 - cell.com
Carrier-free naked mRNA vaccines may reduce the reactogenicity associated with delivery
carriers; however, their effectiveness against infectious diseases has been suboptimal. To …
carriers; however, their effectiveness against infectious diseases has been suboptimal. To …
[HTML][HTML] Toward the Eradication of Herpes Simplex Virus: Vaccination and Beyond
JY Chang, C Balch, HS Oh - Viruses, 2024 - mdpi.com
Herpes simplex virus (HSV) has coevolved with Homo sapiens for over 100,000 years,
maintaining a tenacious presence by establishing lifelong, incurable infections in over half …
maintaining a tenacious presence by establishing lifelong, incurable infections in over half …
[HTML][HTML] Immunological Considerations for the Development of an Effective Herpes Vaccine
M Singer, MI Husseiny - Microorganisms, 2024 - mdpi.com
Research is underway to develop a vaccine to prevent and cure infection from herpes
simplex virus (HSV). It emphasizes the critical need for immunization to address public …
simplex virus (HSV). It emphasizes the critical need for immunization to address public …
Reducing HSV-2 morbidity and mortality: routine serologic screening still not the best answer
MD Pearlman - JAMA, 2023 - jamanetwork.com
Humans are the only natural host and reservoir of herpes simplex virus (HSV) types 1 (HSV-
1) and 2 (HSV-2), and together HSV is among the most prevalent viral infections in the …
1) and 2 (HSV-2), and together HSV is among the most prevalent viral infections in the …
Jet injection potentiates naked mRNA SARS-CoV-2 vaccine in mice and non-human primates by adding physical stress to the skin
S Abbasi, M Matsui-Masai, F Yasui, A Hayashi… - bioRxiv, 2023 - biorxiv.org
Naked mRNA-based vaccines may reduce the reactogenicity associated with delivery
carriers, but their effectiveness has been suboptimal against infectious diseases. Herein, we …
carriers, but their effectiveness has been suboptimal against infectious diseases. Herein, we …
单纯疱疹病毒2 型ICP27377-513 核酸疫苗联合IL-15 核酸疫苗免疫效果的观察.
韩小艳， 吴振村， 周艳， 贾凤珍… - Guangdong Medical …, 2024 - search.ebscohost.com
目的构建表达HIde 病f 2 ç! 细胞OP 27 (infectedcellsprotein27, ICP27) 的Ý 组g pcDNA3.
1rICP27377r513 并34P 细胞2 素(IL) r15Óh 疫Ñ 联ä HSVr2rICP27377r513Óh 疫Ñ …
1rICP27377r513 并34P 细胞2 素(IL) r15Óh 疫Ñ 联ä HSVr2rICP27377r513Óh 疫Ñ …